2nd Quarter - Report

AVENUE SOLUTIONS for MERCK & CO. INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Antibiotics/stewardship; S.1355/H.R.2940, PASTEUR Act of 2023; Value of prescription drugs; Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to HPV vaccine and ACIP recommendations; Issues related to 340b

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE

Bills named: S. 1355 (118th), H.R. 2940 (118th)

Medicare/Medicaid MMM

Value of prescription drugs; Issues related to Medicare Parts B and D; Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; S. 2973, The Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, The Lower Costs, More Transparency Act; S. 1339, The Pharmacy Benefit Manager Reform Act

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1339 (118th), S. 2973 (118th), H.R. 5378 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.